|
1
|
Gardner AJ and Zafonte R:
Neuroepidemiology of traumatic brain injury. Handb Clin Neurol.
138:207–223. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Georgiou AP and Manara AR: Role of
therapeutic hypothermia in improving outcome after traumatic brain
injury: A systematic review. Br J Anaesth. 110:357–367. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ziebell JM and Morganti-Kossmann MC:
Involvement of pro- and anti-inflammatory cytokines and chemokines
in the pathophysiology of traumatic brain injury.
Neurotherapeutics. 7:22–30. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Boer C, Franschman G and Loer SA:
Prehospital management of severe traumatic brain injury: Concepts
and ongoing controversies. Curr Opin Anaesthesiol. 25:556–562.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Si L, Wang H and Wang L: Suppression of
miR-193a alleviates neuroinflammation and improves neurological
function recovery after traumatic brain injury (TBI) in mice.
Biochem Biophys Res Commun. 523:527–534. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Helmy A, Carpenter KL, Menon DK, Pickard
JD and Hutchinson PJ: The cytokine response to human traumatic
brain injury: Temporal profiles and evidence for cerebral
parenchymal production. J Cereb Blood Flow Metab. 31:658–670. 2011.
View Article : Google Scholar :
|
|
7
|
Li T, Zhang YM, Han D, Hua R, Guo BN, Hu
SQ, Yan XL and Xu T: Involvement of IL-17 in secondary brain injury
after a traumatic brain injury in rats. Neuromolecular Med.
19:541–554. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Luo T, Ji WJ, Yuan F, Guo ZZ, Li YX, Dong
Y, Ma YQ, Zhou X and Li YM: Th17/Treg imbalance induced by dietary
salt variation indicates inflammation of target organs in humans.
Sci Rep. 6:267672016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shen Y, Tang XY, Yang YC, Ke X, Kou W, Pan
CK and Hong SL: Impaired balance of Th17/Treg in patients with
nasal polyposis. Scand J Immunol. 74:176–185. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fulton B and Sorkin EM: Propofol. An
overview of its pharmacology and a review of its clinical efficacy
in intensive care sedation. Drugs. 50:636–657. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Marik PE: Propofol: An immunomodulating
agent. Pharmacotherapy. 25:28S–33S. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zheng X, Huang H, Liu J, Li M, Liu M and
Luo T: Propofol attenuates inflammatory response in LPS-activated
microglia by regulating the miR-155/SOCS1 pathway. Inflammation.
41:11–19. 2018. View Article : Google Scholar
|
|
13
|
Yu S, Xin W, Jiang Q and Li A: Propofol
exerts neuroprotective functions by down-regulating microRNA-19a in
glutamic acid-induced PC12 cells. Biofactors. 46:934–942. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shioya M, Obayashi S, Tabunoki H, Arima K,
Saito Y, Ishida T and Satoh J: Aberrant microRNA expression in the
brains of neurodegenerative diseases: miR-29a decreased in
Alzheimer disease brains targets neurone navigator 3. Neuropathol
Appl Neurobiol. 36:320–330. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Di Pietro V, Yakoub KM, Scarpa U, Di
Pietro C and Belli A: MicroRNA signature of traumatic brain injury:
From the biomarker discovery to the point-of-care. Front Neurol.
9:4292018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Henry RJ, Doran SJ, Barrett JP, Meadows
VE, Sabirzhanov B, Stoica BA, Loane DJ and Faden AI: Inhibition of
miR-155 limits neuroinflammation and improves functional recovery
after experimental traumatic brain injury in mice.
Neurotherapeutics. 16:216–230. 2019. View Article : Google Scholar :
|
|
17
|
Li Z, Wang Y, Zeng G, Zheng X, Wang W,
Ling Y, Tang H and Zhang J: Increased miR-155 and heme oxygenase-1
expression is involved in the protective effects of formononetin in
traumatic brain injury in rats. Am J Transl Res. 9:5653–5661.
2017.
|
|
18
|
Chen J, Li Y, Wang L, Zhang Z, Lu D, Lu M
and Chopp M: Therapeutic benefit of intravenous administration of
bone marrow stromal cells after cerebral ischemia in rats. Stroke.
32:1005–1011. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Miyara M, Yoshioka Y, Kitoh A, Shima T,
Wing K, Niwa A, Parizot C, Taflin C, Heike T, Valeyre D, et al:
Functional delineation and differentiation dynamics of human
CD4+ T cells expressing the FoxP3 transcription factor.
Immunity. 30:899–911. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kustrimovic N, Comi C, Magistrelli L,
Rasini E, Legnaro M, Bombelli R, Aleksic I, Blandini F, Minafra B,
Riboldazzi G, et al: Parkinson's disease patients have a complex
phenotypic and functional Th1 bias: Cross-sectional studies of
CD4+ Th1/Th2/T17 and Treg in drug-naive and drug-treated
patients. J Neuroinflammation. 15:2052018. View Article : Google Scholar
|
|
21
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. 4:e050052015. View Article : Google Scholar :
|
|
23
|
Wang P, Ma H, Zhang Y, Zeng R, Yu J, Liu
R, Jin X and Zhao Y: Plasma exosome-derived MicroRNAs as novel
biomarkers of traumatic brain injury in rats. Int J Med Sci.
17:437–448. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang J, Zheng S, Xin N, Dou C, Fu L, Zhang
X, Chen J, Zhang Y, Geng D, Xiao C, et al: Identification of novel
MicroRNA signatures linked to experimental autoimmune myasthenia
gravis pathogenesis: Down-regulated miR-145 promotes pathogenetic
Th17 cell response. J Neuroimmune Pharmacol. 8:1287–1302. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu F, Chen MR, Liu J, Zou Y, Wang TY, Zuo
YX and Wang TH: Propofol administration improves neurological
function associated with inhibition of pro-inflammatory cytokines
in adult rats after traumatic brain injury. Neuropeptides. 58:1–6.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Goodman JC, Van M, Gopinath SP and
Robertson CS: Pro-inflammatory and pro-apoptotic elements of the
neuroinflammatory response are activated in traumatic brain injury.
Acta Neurochir Suppl. 102:437–439. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yu Y, Jian MY, Wang YZ and Han RQ:
Propofol ameliorates calpain-induced collapsin response mediator
protein-2 proteolysis in traumatic brain injury in rats. Chin Med J
(Engl). 128:919–927. 2015. View Article : Google Scholar
|
|
28
|
Shi SS, Zhang HB, Wang CH, Yang WZ, Liang
RS, Chen Y and Tu XK: Propofol attenuates early brain injury after
subarachnoid hemorrhage in rats. J Mol Neurosci. 57:538–545. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Corrigan F, Mander KA, Leonard AV and Vink
R: Neurogenic inflammation after traumatic brain injury and its
potentiation of classical inflammation. J Neuroinflammation.
13:2642016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kuwabara T, Ishikawa F, Kondo M and
Kakiuchi T: The role of IL-17 and related cytokines in inflammatory
autoimmune diseases. Mediators Inflamm. 2017:39080612017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang DD, Zhao YF, Wang GY, Sun B, Kong QF,
Zhao K, Zhang Y, Wang JH, Liu YM, Mu LL, et al: IL-17 potentiates
neuronal injury induced by oxygen-glucose deprivation and affects
neuronal IL-17 receptor expression. J Neuroimmunol. 212:17–25.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lee GR: The balance of Th17 versus Treg
cells in autoimmunity. Int J Mol Sci. 19:7302018. View Article : Google Scholar :
|
|
33
|
Guo H, He Z, Li M, Wang T and Zhang L:
Imbalance of peripheral blood Th17 and Treg responses in children
with refractory Mycoplasma pneumoniae pneumonia. J Infect
Chemother. 22:162–166. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pan YB, Sun ZL and Feng DF: The role of
MicroRNA in traumatic brain injury. Neuroscience. 367:189–199.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chang J, Yan X and Zeng Y: Propofol
weakens hypoxia-aroused apoptosis and autophagy via elevating
microRNA-137 in neurocytes. Exp Mol Pathol. 112:1043272020.
View Article : Google Scholar
|
|
36
|
Mataki H, Seki N, Mizuno K, Kamikawaji K,
Kumamoto T, Koshizuka K, Goto Y and Inoue H: Dual-strand
tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p)
coordinately targeted MTDH in lung squamous cell carcinoma.
Oncotarget. 7:72084–72098. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zheng L, Cheng W, Wang X, Yang Z, Zhou X
and Pan C: Overexpression of MicroRNA-145 ameliorates astrocyte
injury by targeting aquaporin 4 in cerebral ischemic stroke. Biomed
Res Int. 2017:95309512017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang H, Zheng X, Jin J, Zheng L, Guan T,
Huo Y, Xie S, Wu Y and Chen W: LncRNA MALAT1 silencing protects
against cerebral ischemia-reperfusion injury through miR-145 to
regulate AQP4. J Biomed Sci. 27:402020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Baumgart S, Chen NM, Zhang JS, Billadeau
DD, Gaisina IN, Kozikowski AP, Singh SK, Fink D, Ströbel P, Klindt
C, et al: GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs
to Promote Pancreatic Cancer Progression. Mol Cancer Ther.
15:491–502. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Qi H, Yang Z, Dai C, Wang R, Ke X, Zhang
S, Xiang X, Chen K, Li C, Luo J, et al: STAT3 activates
MSK1-mediated histone H3 phosphorylation to promote NFAT signaling
in gastric carcinogenesis. Oncogenesis. 9:152020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Gerlach K, Daniel C, Lehr HA, Nikolaev A,
Gerlach T, Atreya R, Rose-John S, Neurath MF and Weigmann B:
Transcription factor NFATc2 controls the emergence of colon cancer
associated with IL-6-dependent colitis. Cancer Res. 72:4340–4350.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Furman JL, Sompol P, Kraner SD, Pleiss MM,
Putman EJ, Dunkerson J, Mohmmad Abdul H, Roberts KN, Scheff SW and
Norris CM: Blockade of astrocytic Calcineurin/NFAT signaling helps
to normalize hippocampal synaptic function and plasticity in a rat
model of traumatic brain injury. J Neurosci. 36:1502–1515. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhang YJ, Mei HS, Wang C, Wang YL and
Zhang YJ: Involvement of nuclear factor of activated T-cells
(NFATc) in calcineurin-mediated ischemic brain damage in vivo. Yao
Xue Xue Bao. 40:299–305. 2005.PubMed/NCBI
|
|
44
|
Choi MC, Jo J, Park J, Kang HK and Park Y:
NF-κB signaling pathways in osteoarthritic cartilage destruction.
Cells. 8:7342019. View Article : Google Scholar
|
|
45
|
DiDonato JA, Mercurio F and Karin M: NF-κB
and the link between inflammation and cancer. Immunol Rev.
246:379–400. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Qu J, Zhao H, Li Q, Pan P, Ma K, Liu X,
Feng H and Chen Y: MST1 suppression reduces early brain injury by
inhibiting the NF-κB/MMP-9 pathway after subarachnoid hemorrhage in
mice. Behav Neurol. 2018:64709572018. View Article : Google Scholar
|
|
47
|
Zeng J, Chen Y, Ding R, Feng L, Fu Z, Yang
S, Deng X, Xie Z and Zheng S: Isoliquiritigenin alleviates early
brain injury after experimental intracerebral hemorrhage via
suppressing ROS- and/or NF-κB-mediated NLRP3 inflammasome
activation by promoting Nrf2 antioxidant pathway. J
Neuroinflammation. 14:1192017. View Article : Google Scholar
|
